# Abingdon Health > Abingdon Health plc \(AIM: ABDX\): lateral flow and IVD contract development and manufacturing, analytical laboratory services and medtech regulatory\.\.\. Generated by Yoast SEO v28.5, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Documents and reports](https://www.abingdonhealth.com/investors/documents-and-reports/) - [AI and SaMD](https://www.abingdonhealth.com/diagnostics/ai-samd/) - [Regulatory services](https://www.abingdonhealth.com/diagnostics/regulatory-services/) - [New technologies and IVD capabilities](https://www.abingdonhealth.com/diagnostics/ivd-capabilities/) - [CDMO services](https://www.abingdonhealth.com/diagnostics/cdmo-services/) ## Posts - [Validated Once, Compliant Forever? Why Sterilisation Needs a Lifecycle Strategy](https://www.abingdonhealth.com/validated-once-compliant-forever-why-sterilisation-needs-a-lifecycle-strategy/) - [Three Pillars, One Foundation: Aligning IVD Development, Regulation \& Fundraising from Day One](https://www.abingdonhealth.com/aligning-ivd-development-regulation-fundraising-from-day1/): Roadmap of the connection between diagnostic development milestones, regulatory progress, and fundraising stages; and how alignment protects your valuation, timeline and route to market\. - [Case Study: Breakthrough Veterinary Diagnostic for Carus Animal Health](https://www.abingdonhealth.com/case-study-veterinary-diagnostic-carus-animal-health/): Carus Animal Health aimed to develop a point\-of\-care lateral flow test to measure faecal calprotectin in dogs and cats\. - [Case Study: Institut Pasteur Anti\-Malaria Development Project](https://www.abingdonhealth.com/case-study-pvserordt-institut-pasteur/): Abingdon Health plc is creating a rapid serological diagnostic test to identify Plasmodium vivax hypnozoites\. - [Meet Our Breakthrough Eco\-Cassette Materials Partner](https://www.abingdonhealth.com/meet-our-breakthrough-eco-cassette-materials-partner/): Meet the materials partner helping Abingdon Health bring sustainable, eco\-friendly cassettes to lateral flow test manufacture\. ## Events - [Investor Open Day](https://www.abingdonhealth.com/events/shareholder-open-day/): Join us at York Biotech Campus on Wednesday 21 October 2026 for a guided tour of our lateral flow facility and Q\&A with the senior management team\. - [Medica](https://www.abingdonhealth.com/events/medica/): MEDICA 2026 is the world's leading medical trade fair, bringing together healthcare professionals, technology innovators, manufacturers, policymakers, and industry leaders from across the globe\. The… - [Wisconsin Biohealth Summit 2026](https://www.abingdonhealth.com/events/wisconsin-biohealth-summit-2026/): The Wisconsin Biohealth Summit 2026 brings together scientists, clinicians, innovators, investors, and industry leaders from across the biohealth ecosystem to explore how breakthroughs move from\.\.\. - [HLTH USA 2026](https://www.abingdonhealth.com/events/hlth-usa-2026/): HLTH USA 2026 is one of the healthcare industry’s leading innovation events, bringing together more than 12,000 healthcare leaders, innovators, investors, providers, payers, policymakers, and\.\.\. - [NATO Medical Innovation Workshop 2026](https://www.abingdonhealth.com/events/nato-medical-innovation-workshop-2026/): The NATO Medical Innovation Workshop 2026 brings together military medicine leaders, innovation teams, academia, and industry to explore cutting\-edge healthcare solutions for complex operational\.\.\. ## Videos - [Final results for the year ended 30 June 2026](https://www.abingdonhealth.com/videos/final-results-for-the-year-ended-30-june-2026/) - [Virtual Investor Conferences](https://www.abingdonhealth.com/videos/virtual-investor-conferences/) - [From Diagnostic Vision to Commercial Reality](https://www.abingdonhealth.com/videos/from-diagnostic-vision-to-commercial-reality/): Your end\-to\-end lateral flow CDMO partner in the UK and USA\. At Abingdon Health, we accelerate your product's route to market by integrating lateral flow development, scale\-up, and manufacturing with… - [Investor Presentation: ABDX Trading Overview for Six Months to 31\-Dec\-2025](https://www.abingdonhealth.com/videos/abdx-investor-presentation-trading-overview-for-6m-to-31-dec-2025/): Abingdon Health PLC \(AIM:ABDX\) CEO Dr Chris Hand talked with Proactive at the One2One Investor Forum about the company’s strong recent performance and expanding capabilities in the MedTech sector\. - [UK \& USA Lateral Flow and IVD Development Services](https://www.abingdonhealth.com/videos/uk-usa-lateral-flow-ivd-cdmo/): Two continents\. One partner\. Zero compromise\. Abingdon Health offers integrated CDMO and CRO services for in vitro diagnostics and lateral flow product development customers, on both sides of the… ## Brochures \& guides - [Abingdon Analytical Performance Evaluation Brochure](https://www.abingdonhealth.com/guides/abingdon-analytical-performance-evaluation-brochure/): Analytical and clinical performance studies from our UKAS ISO/IEC 17025 accredited laboratory, planned around FDA, IVDR and UK submissions\. - [Abingdon AI \& MedTech Brochure](https://www.abingdonhealth.com/guides/abingdon-ai-medtech-brochure/): Regulatory, quality and clinical support for medical devices, SaMD and AI\-enabled products across the US, EU, UK and 90\+ territories\. - [Eco\-Housings Brochure](https://www.abingdonhealth.com/guides/eco-housings-brochure/): Compostable, seaweed\-based housings for lateral flow tests: equivalent performance on the same production lines, with no plastic\. - [Group CDMO \& CRO Services Brochure](https://www.abingdonhealth.com/guides/group-cdmo-cro-brochure/): Specialist expertise provided by Abingdon Health Group companies, covering lateral flow CRO and CDMO services, IVD analytical services, and IVD and MedTech regulatory support\. Key service areas… - [Companion Diagnostics Partnering Services](https://www.abingdonhealth.com/guides/companion-diagnostics-partnering-services/): Complex diagnostic technologies specialists, delivering comprehensive end\-to\-end Companion Diagnostic \(CDx\) product development services\. Key service areas include: Integrated lateral flow CDMO… ## News - [30% revenue growth and progression to adjusted EBITDA profitability in H2 FY26](https://www.abingdonhealth.com/news/30-revenue-growth-and-progression-to-adjusted-ebitda-profitability-in-h2-fy26/) - [Abingdon Analytical: UKAS ISO/IEC 17025 Accreditation](https://www.abingdonhealth.com/news/abingdon-analytical-ukas-iso-iec-17025-accreditation/) - [Official Opening of USA Manufacturing Hub](https://www.abingdonhealth.com/news/official-opening-of-usa-manufacturing-hub/): Announcement of the official opening yesterday of our new manufacturing hub at our site at University Research Park in Madison, Wisconsin, USA - [Trading Update: Half Year to 30th June 2026](https://www.abingdonhealth.com/news/trading-update-half-year-to-30th-june-2026/): 31% increase in full year revenues and progression to EBITDA profitability in H2 York, UK and Madison, WI, USA, 29 July 2026: Abingdon Health… - [USA Manufacturing Site Expansion](https://www.abingdonhealth.com/news/usa-manufacturing-site-expansion/) ## Categories - [Blog](https://www.abingdonhealth.com/category/blog/) - [Case Studies](https://www.abingdonhealth.com/category/case-studies/) ## Optional - [Sitemap index](https://www.abingdonhealth.com/sitemap_index.xml)